Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
Hematology Reports · 2009
DOI: 10.4081/hr.2009.e11 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematology Reports, 2009. Verfasst von Hans E. Johnsen und 9 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Johnsen, H. E., Knudsen, L. M., Mylin, A. K., Gimsing, P., Gregersen, H., Abildgaard, N., Andersen, N. F., Plesner, T., Vangsted, A., & Mourits-Andersen, T. (2009). Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial. Hematology Reports. https://doi.org/10.4081/hr.2009.e11
Vancouver
Johnsen HE, Knudsen LM, Mylin AK, Gimsing P, Gregersen H, Abildgaard N, et al. Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial. Hematology Reports. 2009. doi:10.4081/hr.2009.e11
BibTeX
@article{Johnsen2009,
author = {Johnsen, Hans E. and Knudsen, Lene M. and Mylin, Anne K. and Gimsing, Peter and Gregersen, Henrik and Abildgaard, Niels and Andersen, Niels Frost and Plesner, Torben and Vangsted, Annette and Mourits-Andersen, Torben},
title = {Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial},
journal = {Hematology Reports},
year = {2009},
doi = {10.4081/hr.2009.e11}
}
EUVIMED